Navigation Links
NxStage® Reports Fourth Quarter and Full-Year 2010 Financial Results; Revenue Growth Exceeds Company Guidance
Date:2/17/2011

edDecember 31,December 31,2010200920102009Revenues

$49,769$40,510$179,218$148,676Cost of revenues

32,17729,063121,091111,812Gross profit

17,59211,44758,12736,864Operating expenses:Selling and marketing

9,1327,95634,16630,047Research and development

3,5312,43412,9009,814Distribution

3,9203,44214,75113,918General and administrative

6,1705,02022,77419,532Total operating expenses

22,75318,85284,59173,311Loss from operations

(5,161)(7,405)(26,464)(36,447)Other expense:Interest income

33335Interest expense

(1,165)(1,020)(4,597)(6,522)Other income (expense), net

242(288)114(268)(920)(1,305)(4,480)(6,755)Net loss before income taxes

(6,081)(8,710)(30,944)(43,202)Provision for income taxes

212(33)768265Net loss

$ (6,293)$ (8,677)$ (31,712)$ (43,467)Net loss per share, basic and diluted

$   (0.13)$   (0.19)$
(0.66)$
(0.93)Weighted-average shares outstanding, basic and diluted

50,23346,70448,18846,627NxStage Medical, Inc.Consolidated Balance Sheets(amount in thousands, except share data)(unaudited)December 31,December 31,20102009ASSETSCurrent assets:Cash and cash equivalents

$
4,339$
21,720Accounts receivable, net

14,10714,238Inventory

34,95028,117Prepaid expenses and other current assets

2,0841,227Total current assets

155,48065,302Property and equipment, net

8,29010,336Field equipment, net

13,66021,726Deferred cost of revenues

40,08127,799Intangible assets, net

25,41228,208Goodwill

42,69842,698Other assets

473909Total assets

$
286,094$
96,978LIABILITIES AND STOCKHOLDERS’ EQUITYCurrent liabilities:Accounts payable

$
,811$
9,827Accrued expenses

19,5379,377Current portion of long-term debt

4361Total current liabilities

36,39129,265Deferred revenues

55,36638,490Long-term debt

40,45437,854
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. NxStage® to Report Fourth Quarter and Full Year 2010 Financial Results
2. NxStage® Appoints Nancy J. Ham to Its Board of Directors and Announces Resignation of Board Member Jonathan T. Silverstein
3. First NxStage® Home Hemodialysis Patients Celebrate Seven-Year Anniversary
4. NxStage® Expands Product Portfolio With Innovative Patient Access Surveillance Solution From Vasc-Alert™
5. Regeneron Reports Full Year and Fourth Quarter 2010 Financial and Operating Results
6. InterMune Reports Fourth Quarter and Full Year 2010 Financial Results and Business Highlights
7. Masimo Reports Fourth Quarter and Full Year 2010 Financial Results; Provides 2011 Guidance
8. Allscripts Reports Fourth Quarter Results
9. Mesa Labs Reports 44% Increase in Third Quarter Revenues
10. ThermoGenesis Reports Second Quarter 2011 Results; Increased Presence in China
11. Cambrex Reports Fourth Quarter and Full Year 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... , Oct. 30, 2014 Boston Scientific ... participate in the 2014 Credit Suisse Annual Healthcare Conference ... , AZ.  Dan Brennan , executive vice ... about the company beginning at approximately 8:00 a.m. PT ... A live webcast of the presentation and question and ...
(Date:10/30/2014)... 2014  Nektar Therapeutics (Nasdaq: NKTR ) ... ended September 30, 2014 on Thursday, November 6, 2014, ... Robin , president and chief executive officer, will host ... 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... audio-only Webcast of the conference call can be accessed ...
(Date:10/30/2014)...   Auxilium Pharmaceuticals , Inc. (NASDAQ: ... company, today announced financial results for the third ... important corporate, commercial, regulatory and clinical development updates ... very pleased with the continued momentum and strong ... portfolio this quarter, especially the XIAFLEX franchise, which ...
Breaking Medicine Technology:Boston Scientific To Participate In 2014 Credit Suisse Annual Healthcare Conference 2Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets 2Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 2Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 3Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 4Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 5Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 6Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 7Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 8Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 9Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 10Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 11Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 12Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 13Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 14Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 15Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 16Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 17Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 18Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 19Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 20Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 21Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 22
... in Combination with CRESTOR (rosuvastatin calcium) Improved LDL, HDL ... ... SEATTLE, May 31 New Phase III data showed,that in ... AstraZeneca,s CRESTOR(R) (rosuvastatin,calcium) led to greater improvements than the corresponding ...
... Annual Meeting -, SOUTH SAN FRANCISCO, ... Pharmaceuticals, Inc. (Nasdaq: PARD ), a ... safety and,efficacy data from its ongoing Phase ... docetaxel and prednisone, the standard of care ...
Cached Medicine Technology:Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids 2Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids 3Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids 4Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 2Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 3Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 4
(Date:10/30/2014)... Paramount Rx, a full-service prescription benefits manager ... help people save money through its innovative discount card ... drugs in the new health care system, the Paramount ... the relationship between consumers, businesses and the pharmacy industry. ... face today with medical costs is the rising price ...
(Date:10/30/2014)... Canada (PRWEB) October 30, 2014 Home ... area’s leading provider of non-medical, in-home senior care, is ... to increased brain health. , The study, performed by ... ages of 60 and 78 over a week-long period ... opposed to daily physical activity. By examining the structural ...
(Date:10/30/2014)... October 30, 2014 REV'D Provision Co. ... now available through a unique service called, The ... to empower the everyday athlete. The Feed has taken ... and created a system to pass that information on ... REV’D® is now available on The Feed!” says REV’D® ...
(Date:10/30/2014)... When it comes to heart disease, a new study finds ... they have symptoms that spell trouble. "The main danger ... more severe or advanced stage of heart disease, there are ... Fulbright Scholar and research fellow at the Harvard School of ... and Stroke Foundation of Canada. In the study, researchers ...
(Date:10/30/2014)... a low-carb, high-fat diet could help control epilepsy that ... A review of five studies found that a ... like bacon, eggs, heavy cream, butter, fish and green ... doesn,t improve with medication. "We need new treatments ... seizures are not stopped by medications," study co-author Dr. ...
Breaking Medicine News(10 mins):Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 3Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 2Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 3Health News:Nutrition Experts at TheFeed.com Get REV'D 2Health News:Nutrition Experts at TheFeed.com Get REV'D 3Health News:Women Often Ignore Signs of Heart Trouble 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 3
... , TUESDAY, June 29 (HealthDay News) -- Scientists report ... older women by causing certain genetic mutations. The study ... National Cancer Institute. . Previous research has indicated that ... develop colorectal cancer than those who never smoked, according to ...
... ... employers who want to provide health benefits and control costs., , ... Minneapolis, MN (PRWEB) June 29, 2010 ... largest independent insurance and employee benefits brokers in the Midwest, to offer customized defined ...
... ... Symptom Checker, a new online tool to help users evaluate their child,s symptoms. The tool ... ... if your child develops a fever, cough, vomiting, rash, sore throat or head injury? A ...
... HealthDay Reporter , TUESDAY, June 29 (HealthDay News) -- Type ... that continuously monitored their blood sugar levels had better control ... clinical trial finds. , , Researchers divided 485 people ... multiple daily insulin injections and tested their blood sugar throughout ...
... the Ohio State University Comprehensive Cancer Center-Arthur G. ... Institute (OSUCCC-James) have discovered how a substance that ... can block the proliferation of cancer cells. ... may have anticancer effects and other health benefits, ...
... powerful and highly addictive psychostimulant that is toxic to ... many parts of the United States. The National Institute ... Americans have tried methamphetamine, while more than 1.4 million ... the drug can lead to devastating medical, psychological and ...
Cached Medicine News:Health News:Bloom Health and Christensen Group Partner Together to Deliver Innovative Solution 2Health News:AAP Offers New Online Pediatric Symptom Checker on HealthyChildren.org 2Health News:Insulin Pump With Blood Sugar Sensor May Improve on Injections 2Health News:Insulin Pump With Blood Sugar Sensor May Improve on Injections 3Health News:Study shows how dietary supplement may block cancer cells 2Health News:Dental school gets $1.86 million from NIH for study of methamphetamine's effect on oral health 2
Straight shafts with polished finish. Teeth: 0.12 mm. Tying platform: 5.0 mm. Wide Serrated....
Angled 45 degree shafts with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Straight shafts with 1 x 2 teeth and 6 mm tying platform. Wide serrated handle with polished finish....
Straight shafts with 1 x 2 teeth and serrated handle with polished finish....
Medicine Products: